People In Brief
This article was originally published in The Tan Sheet
Executive Summary
Hennessey jumps to Prestige from Pfizer
You may also be interested in...
In Brief
EC drug goes nonprescription in Ireland
House Shows Nanotech Safety Interest With Bill To Sharpen Federal Plan
The House Committee on Science and Technology will consider legislation crafted to provide strategic direction to the federal research program for nanotechnology
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.